Global Health and Development Finance: ESG BROADCAST shares key takeaways.
Gavi, the Vaccine Alliance, and the World Bank Group (WBG) have significantly deepened their partnership by signing a new Memorandum of Understanding (MoU) on December 6, 2025. This collaboration is designed to strengthen financing for immunization and primary healthcare systems, while strategically supporting regional vaccine manufacturing capabilities, particularly across Africa. The agreement emphasises a commitment to equitable access and sustainable health security in low- and lower middle-income countries.
The primary financial commitment involves mobilizing at least US$2 billion in joint financing over the next five years (2026–2030), directly aligned with the priorities of partner nations. This funding aims to support countries in achieving self-reliance and transitioning from relying solely on external support to establishing long-term sustainable financing mechanisms. World Bank Group President Ajay Banga emphasized that this joint effort supports the WBG’s larger goal of delivering quality health services to 1.5 billion people by 2030.
A critical component of the collaboration is the focus on supporting countries as they build robust and resilient health systems. This includes leveraging innovative financing tools such as blended finance, buydowns, and guarantees, coupled with joint technical support in areas like public financial management. Gavi CEO Dr. Sania Nishtar noted that these additional resources will be instrumental for the Gavi Leap agenda, which aims to accelerate progress toward country ownership and self-reliance in the health sector.
The partnership also addresses global vaccine equity, a lesson learned sharply during the COVID-19 pandemic, by advancing regional vaccine manufacturing. This effort is explicitly aligned with the African Union’s ambitious goal of producing 60% of the continent’s vaccine supply domestically by 2040. The Gavi African Vaccine Manufacturing Accelerator (AVMA) will work closely with the WBG to build regulatory frameworks, strengthen local supply chains, and enhance workforce development, all necessary steps for a self-sustaining regional ecosystem.
Furthermore, strengthening primary care approaches is central to the strategy, generating employment across the health workforce and supporting local supply chains and supporting industries. Since launching its health initiative 18 months ago, the World Bank Group has already helped reach 375 million more people with quality, affordable services. This renewed collaboration strengthens the foundation for achieving broader human development and economic growth alongside health system resilience.
Strategic significance lies in how this collaboration fundamentally addresses systemic risks under the Social and Governance pillars of ESG. For global investors, the mobilization of $2 billion signals a robust commitment to closing global health equity gaps, aligning directly with Sustainable Development Goal 3 (Good Health and Well-being). The focus on regional manufacturing directly enhances supply chain resilience and national sovereignty, translating public health investment into long-term economic stability and reduced geopolitical risk for operations in emerging markets, thus demanding new standards for corporate and sovereign governance disclosure regarding access and security.
